Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases - a systematic review

被引:26
作者
Lurvink, Robin J. [1 ]
Rovers, Koen P. [1 ]
Nienhuijs, Simon W. [1 ]
Creemers, Geert-Jan [2 ]
Burger, Jacobus W. A. [1 ]
de Hingh, Ignace H. J. [1 ,3 ]
机构
[1] Catharina Hosp, Dept Surg, Eindhoven, Netherlands
[2] Catharina Hosp, Dept Med Oncol, Eindhoven, Netherlands
[3] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
关键词
Pressurized intraperitoneal aerosol chemotherapy (PIPAC); colorectal cancer; peritoneal metastases; oxaliplatin; LOW-DOSE CISPLATIN; QUALITY-OF-LIFE; GASTRIC-CANCER; OVARIAN-CANCER; OCCUPATIONAL-HEALTH; INITIAL-EXPERIENCE; CARCINOMATOSIS; DOXORUBICIN; THERAPY; SAFETY;
D O I
10.21037/jgo-20-257
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) is increasingly used as a palliative treatment option for patients with colorectal peritoneal metastases (CPM). The present study aimed to systematically review all clinical studies reporting safety and efficacy outcomes of PIPAC-OX in patients with CPM.. PubMed, EMBASE, The Cochrane Library, and CINAHL were systematically searched to identify all clinical studies that included at least one patient with CPM treated with PIPAC-OX and reported one of the following outcomes: adverse events, tumor response, quality of life, secondary cytoreductive surgery, progression-free survival, overall survival, and environmental safety of PIPAC-OX. Results were narratively described. Of 28 included studies, only 14 non-comparative studies separately reported at least one outcome of PIPAC-OX for CPM, of which only two studies specifically focused on this group. These 14 studies reported adverse events (5 studies), tumor response (5 studies), secondary cytoreductive surgery (4 studies), progression-free survival (1 study), overall survival (5 studies), and environmental safety (2 studies). Except for 5 studies (describing 26 patients), none of the included studies stratified their results for PIPAC-OX monotherapy and PIPAC-OX with concomitant systemic therapy, and none of the studies reporting survival outcomes stratified results for line of palliative treatment, complicating interpretation. No PIPAC-OX related deaths were reported. No occupational platinum was detected during PIPAC-OX. The available evidence regarding PIPAC-OX for CPM. is limited and difficult to interpret. Despite these limitations, PIPAC-OX appears safe in patients with CPM and safe for operating personnel. To increase insight in the role of PIPAC-OX in this setting, investigators of ongoing and future studies are encouraged to report separate outcomes of PIPAC-OX for CPM, to stratify their results for PIPAC-OX monotherapy and PIPAC-OX with concomitant systemic therapy, and to stratify survival results for line of palliative treatment.
引用
收藏
页码:S242 / +
页数:20
相关论文
共 90 条
[1]   Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer [J].
Alyami, Mohammad ;
Bonnot, Pierre-Emmanuel ;
Mercier, Frederic ;
Laplace, Nathalie ;
Villeneuve, Laurent ;
Passot, Guillaume ;
Bakrin, Naoual ;
Kepenekian, Vahan ;
Glehen, Olivier .
EJSO, 2021, 47 (01) :123-127
[2]   Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications [J].
Alyami, Mohammad ;
Hubner, Martin ;
Grass, Fabian ;
Bakrin, Naoual ;
Villeneuve, Laurent ;
Laplace, Nathalie ;
Passot, Guillaume ;
Glehen, Olivier ;
Kepenekian, Vahan .
LANCET ONCOLOGY, 2019, 20 (07) :E368-E377
[3]   Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [J].
Alyami, Mohammad ;
Mercier, Frederic ;
Siebert, Matthieu ;
Bonnot, Pierre-Emmanuel ;
Laplace, Nathalie ;
Villeneuve, Laurent ;
Passot, Guillaume ;
Glehen, Olivier ;
Bakrin, Naoual ;
Kepenekian, Vahan .
EJSO, 2021, 47 (01) :128-133
[4]   Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis [J].
Alyami, Mohammad ;
Gagniere, Johan ;
Sgarbura, Olivia ;
Cabelguenne, Delphine ;
Villeneuve, Laurent ;
Pezet, Denis ;
Quenet, Francois ;
Glehen, Olivier ;
Bakrin, Naoual ;
Passot, Guillaume .
EJSO, 2017, 43 (11) :2178-2183
[5]   Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)? [J].
Ametsbichler, Paul ;
Boehlandt, Antje ;
Nowak, Dennis ;
Schierl, Rudolf .
EJSO, 2018, 44 (11) :1793-1799
[6]   Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis [J].
Benzerdjeb, Nazim ;
Durieux, Emeline ;
Tantot, Juliet ;
Isaac, Sylvie ;
Fontaine, Juliette ;
Harou, Olivier ;
Glehen, Olivier ;
Kepenekian, Vahan ;
Alyami, Mohammad ;
Villeneuve, Laurent ;
Laplace, Nathalie ;
Traverse-Glehen, Alexandra ;
Shisheboran-Devouassoux, Mojgan ;
Bakrin, Naoual .
HISTOPATHOLOGY, 2020, 77 (04) :548-559
[7]   Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) [J].
Blanco, Ana ;
Giger-Pabst, Urs ;
Solass, Wiebke ;
Zieren, Juergen ;
Reymond, Marc A. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) :2311-2316
[8]   Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center [J].
Ceribelli, C. ;
Debs, T. ;
Chevallier, A. ;
Piche, M. A. ;
Bereder, J. M. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2020, 34 (06) :2803-2806
[9]   Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial [J].
De Simone, Michele ;
Vaira, Marco ;
Argenziano, Monica ;
Berchialla, Paola ;
Pisacane, Alberto ;
Cinquegrana, Armando ;
Cavalli, Roberta ;
Borsano, Alice ;
Robella, Manuela .
BIOMEDICINES, 2020, 8 (05)
[10]   Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow [J].
Delhorme, J-B ;
Klipfel, A. ;
D'Antonio, F. ;
Greget, M-C ;
Diemunsch, P. ;
Rohr, S. ;
Romain, B. ;
Brigand, C. .
JOURNAL OF VISCERAL SURGERY, 2019, 156 (06) :485-488